In parallel, we developed a second-generation DSR® product (DSR® 2.0), a proprietary sodium-free dextrose / icodextrin solution expected to have an improved therapeutic and …
0 in H1 2023 The Company is progressing development of its proprietary DSR 2.0 product, a sodium-free dextrose / icodextrin solution expected to have an improved therapeutic and …
